Table 4.
Pre-test and post-test probabilities of malignancy after applying the diagnostic model to Vanderbilt’s patients with an intermediate risk of malignancy based on nodule size (9–15 mm)
| Patient | Sex | Smoking status | Nodule size (mm) | Cancer histology | Pretest probability | Post-test probability |
|---|---|---|---|---|---|---|
| 13 | Female | Former | 11 | ADC | 4.7% | 100% |
| 14 | Male | Current | 11 | SCLC | 4.7% | 100% |
| 16 | Male | Former | 12.5 | SCC | 4.7% | 5.7% |
| 19 | Female | Former | 13.5 | SCLC | 4.7% | 12% |
| 21 | Female | Former | 14 | ADC | 4.7% | 45.2% |
| 25 | Male | Former | 14.5 | ADC | 4.7% | 8.5% |